Vnitr Lek 2021, 67(7):394-398 | DOI: 10.36290/vnl.2021.106

In general medicine surplus of care can harm the patients

Luboš Kotík
Interní klinika, Fakultní Thomayerova nemocnice Praha

Article brings several chosen topics, where in therapy and diagnostic would less be more, that are very often dealt by so called generalists, experts with broad knowledge in medicine. Those are first of all internists and general practitioners.

Keywords: anticoagulation, biomarkers of inflamation, proton pump inhibitors, pharmocological interactions, polypramasia, pulmonary embolism.

Published: November 1, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kotík L. In general medicine surplus of care can harm the patients. Vnitr Lek. 2021;67(7):394-398. doi: 10.36290/vnl.2021.106.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. American Society of Health‑System Pharmacists. Five Things Physicians and Patients Should Question. Choosing wisely, Released June 1, 2017; #1, 3 & 4 updated June 20, 2019. www: https://choosingwisely.org/societies/american‑society‑of‑health‑system‑pharmacists/
    2. Cook D, Guyatt G. Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients. N Engl J Med 2018; 378: 2506-2516, DOI: 10.1056/NEJMra1605507. Go to original source... Go to PubMed...
    3. Nigam H Shah, Paea LePendu. Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population Published: June 10, 2015, Plos One. https://doi.org/10.1371/journal.pone.0124653 DOI: 10.1371/journal.pone.0124653. Go to original source... Go to PubMed...
    4. Amit S Chitnis, Stacy M Holzbauer et al. Epidemiology of Community‑Associated Clostridium difficile Infection 2009, Through 2011. JAMA Intern Med 2013; 173(14): 1359-1367. doi:10.1001/jamainternmed.2013.7056. Go to original source... Go to PubMed...
    5. Shao YHJ, Chan TS, Tsai K, Wu SY. Association Between Proton Pump Inhibitors and the Risk of Hepatocellular Carcinoma. Aliment Pharmacol Ther. 2018; 48(4): 460-468. Go to original source... Go to PubMed...
    6. Antoniou T, Macdonald EM et al. Proton pump inhibitors and the risk of acute kidney injury in older patients: a population based cohort study. CmajOpen, doi: 10.9778/cmajo.20140074 cmajo April 16, 2015 vol. 3 no. 2 E166-E171. Go to original source...
    7. Yan Xie, Bowe M et al. Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study. BMJ 2019; 365:l1580, doi:.org/10.1136/bmj.l1580 (Published 30 May 2019). Go to original source... Go to PubMed...
    8. Savarino V, Dulbecco P et al. The appropriate use of proton pump inhibitors (PPIs): Need for a reappraisal. Eur. J. of Internal Med., DOI: http://dx.doi.org/10.1016/j.ejim. 2016. 10. 007. Go to original source...
    9. Lee CT, McDonald EG. Deprescribing Proton Pump Inhibitors: Overcoming Resistance. JAMA Intern Med. Published online February 24: 2020. doi:10.1001/jamainternmed.2020.0040. Go to original source... Go to PubMed...
    10. Green AR, Aschmann H et al. Assessment of Patient‑Preferred Language to Achieve Goal‑Aligned Deprescribing in Older Adults. JAMA Netw Open 2021; 4(4): e212633. doi:10.1001/jamanetworkopen.2021.2633. Go to original source... Go to PubMed...
    11. Klok FA, Huisman MV. How I assess and manage the risk of bleeding in patients treated for venous thromboembolism. Blood (2020) 135 (10): 724-734. https://doi.org/10.1182/blood.2019001605. Go to original source... Go to PubMed...
    12. Hoirisch‑Clapauch S, Nardi AE. Antidepressants: bleeding or thrombosis? Trombosis research. September 01 2019; 181 (Supplement 1): S23-S28. DOI:https://doi.org/10.1016/S0049-3848(19)30362-7. Go to original source... Go to PubMed...
    13. De Filette J, Cichiels V. Bleeding interaction between fluconazole and warfarin. Lancet Published: September 29: 2018. DOI:https://doi.org/10.1016/S0140-6736(18)32217-7. Go to original source... Go to PubMed...
    14. Villanueva C, Colomo A, et al. Transfusion Strategies for Acute Upper Gastrointestinal Bleeding. N Engl J Med 2013; 368: 11-21 January 3, 2013DOI: 10.1056/NEJMoa1211801. Go to original source... Go to PubMed...
    15. Soylemez W, Schwarts LM, Woloshin S. Time Trends in Pulmonary Embolism in the United States Evidence of Overdiagnosis. Arch Intern Med. 2011; 171(9): 831-837. doi:10.1001/archinternmed.2011.178. Go to original source... Go to PubMed...
    16. Diffin DC, Leyendecker JR, Johnson SR. Effect ofAnatomic Distribution of Pulmonary Emboli on Interobserver Agreement in the Interpretation of Pulmonary Angiography AJR1998:171:1085 Go to original source...
    17. Baumgartner C, Tritschler T. Clinical significance of subsegmental pulmonary embolism: An ongoing controversy. Rpth, First published: 09 December 2020, https://doi.org/10.1002/rth2.12464 Go to original source... Go to PubMed...
    18. Chandrashekara T. C‑reactive protein: An inflammatory marker with specific role in physiology, pathology, and diagnosis IJRCI. 2014; 2(S1): SR3. Go to original source...
    19. Nora D, Salluh J et al. Biomarker‑guided antibiotic therapy-strengths and limitations. Ann Transl Med. 2017 May; 5(10): 208. doi: 10.21037/atm.2017. 04. 04. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.